Dantrolene: Clinical Trials

4 trials of Dantrolene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Recruiting 1
Phase 24Completed 3, Recruiting 1

Follow Dantrolene: new trials by email Literature Review of Dantrolene trials Research Report on Dantrolene

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Cilostazol, Leucovorin, Pirfenidone - Multiple Sclerosis
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)2502017-08-112026-10-20
A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
dantrolene sodium - Wolfram Syndrome, Diabetes Mellitus
Phase 1 / Phase 2CompletedWashington University School of Medicine212017-01-012024-03-13
Safety Study of Dantrolene in Subarachnoid Hemorrhage
Dantrolene, Placebo - Subarachnoid Hemorrhage, Cerebral Vasospasm
Phase 1 / Phase 2CompletedUniversity of Massachusetts, Worcester312009-10-012015-03-05
Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage
Dantrolene - Cerebral Vasospasm After Subarachnoid Hemorrhage
Phase 1 / Phase 2CompletedUniversity of Massachusetts, Worcester102007-07-012012-05-25

Conditions studied

Subarachnoid Hemorrhage (2)  ·  Aneurysm (1)  ·  Ataxia (1)  ·  Diabetes Mellitus (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)  ·  Optic Atrophy (1)  ·  Vasospasm, Intracranial (1)  ·  Wolfram Syndrome (1)

Sponsors

University of Massachusetts, Worcester (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)

Top investigators

Susanne Muehlschlegel, MD (2)  ·  Bibiana Bielekova, M.D. (1)  ·  Fumihiko Urano, MD (1)  ·  John R Sims, MD (1)

Results publications

PMID 21454813, PMID 25344064, PMID 34185708, PMID 40371642

NIH funding

R21DK113487 (1)